AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 200 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $165 | -99.9% | 21,182 | -4.3% | 0.00% | 0.0% |
| Q2 2022 | $222,000 | -97.8% | 22,126 | -97.2% | 0.00% | -97.3% |
| Q1 2022 | $9,919,000 | -33.9% | 801,197 | +22.1% | 0.07% | -11.0% |
| Q4 2021 | $15,007,000 | +65.1% | 656,205 | +59.7% | 0.08% | +90.7% |
| Q3 2021 | $9,091,000 | +319.7% | 410,788 | +145.8% | 0.04% | +330.0% |
| Q2 2021 | $2,166,000 | +129.4% | 167,110 | +129.8% | 0.01% | +100.0% |
| Q1 2021 | $944,000 | +816.5% | 72,732 | +1324.7% | 0.01% | +400.0% |
| Q4 2019 | $103,000 | -58.1% | 5,105 | -88.9% | 0.00% | -50.0% |
| Q3 2019 | $246,000 | -68.6% | 46,114 | -87.6% | 0.00% | -71.4% |
| Q4 2016 | $784,000 | -30.2% | 373,209 | 0.0% | 0.01% | -41.7% |
| Q3 2016 | $1,123,000 | – | 373,209 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
| Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
| Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
| DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
| NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
| Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
| KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |